Brazil Bans Import of Lupin APIs

Source: Press Trust of India

Jul 09, 2015

Brazilian drug regulator ANVISA has suspended import of active pharmaceutical ingredients produced by India's Lupin citing "unsatisfactory inputs" and GMP deviations.

According to ANVISA, it has suspended imports of "all beta-lactam cephalosporin pharmaceutical ingredients and all imported drugs using these inputs" manufactured by Lupin.

A Lupin spokesperson says ANVISA had inspected the cephalosporin facility near Bhopal in central India and had certain observations, which have since been addressed.

Read the Profit article

Return to the Web Watcher Newsletter  

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments